S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Henry Ford Would NEVER Have Seen This Coming (Ad)
How to find blue-chip dividend stocks
Ex dividend date vs record date: What’s the difference?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Henry Ford Would NEVER Have Seen This Coming (Ad)
How to find blue-chip dividend stocks
Ex dividend date vs record date: What’s the difference?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Henry Ford Would NEVER Have Seen This Coming (Ad)
How to find blue-chip dividend stocks
Ex dividend date vs record date: What’s the difference?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Henry Ford Would NEVER Have Seen This Coming (Ad)
How to find blue-chip dividend stocks
Ex dividend date vs record date: What’s the difference?
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Last chance to set up your portfolio for OPEC cuts
What does consumer price index measure?
Top-Rated StocksTop-Rated

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

$493.81
+2.21 (+0.45%)
(As of 12/6/2023 ET)
Compare
Today's Range
$491.65
▼
$496.68
50-Day Range
$431.52
▼
$506.41
52-Week Range
$415.60
▼
$609.85
Volume
1.23 million shs
Average Volume
1.57 million shs
Market Capitalization
$190.79 billion
P/E Ratio
32.36
Dividend Yield
0.28%
Price Target
$593.94
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Thermo Fisher Scientific Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Analysts' Consensus Price Target

$593.94
20.28% Upside
High Forecast$711.00
Average Forecast$593.94
Low Forecast$475.00
TypeCurrent Forecast
12/7/22 to 12/7/23		1 Month Ago
11/7/22 to 11/7/23		3 Months Ago
9/8/22 to 9/8/23		1 Year Ago
12/7/21 to 12/7/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
14 Buy rating(s)
11 Buy rating(s)
7 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$593.94$593.94$631.71$623.11
Predicted Upside20.28% Upside17.02% Upside12.04% Upside16.93% Upside
Get Thermo Fisher Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.


TMO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Thermo Fisher Scientific Stock vs. The Competition

TypeThermo Fisher ScientificMedical CompaniesS&P 500
Consensus Rating Score
2.88
2.67
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside20.28% Upside654.57% Upside2,089.55% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/26/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$660.00 ➝ $530.00+20.54%
10/26/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$657.00 ➝ $579.00+30.19%
10/26/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$625.00 ➝ $530.00+19.26%
10/26/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$580.00 ➝ $515.00+16.10%
10/26/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Sector Weight
10/25/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderweight ➝ Equal Weight$475.00+11.02%
10/24/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$640.00 ➝ $600.00+29.92%
10/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$670.00 ➝ $630.00+29.65%
9/29/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$625.00 ➝ $585.00+16.22%
9/28/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$603.00+21.01%
7/27/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform$664.00 ➝ $625.00+8.66%
7/13/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Outperform$620.00+17.89%
4/4/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform$615.00 ➝ $610.00+5.31%
2/2/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform$620.00 ➝ $630.00+7.26%
2/2/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform$690.00 ➝ $711.00+21.05%
12/13/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$620.00+8.51%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:33 AM ET.












TMO Price Target - Frequently Asked Questions

What is Thermo Fisher Scientific's consensus rating and price target?

According to the issued ratings of 16 analysts in the last year, the consensus rating for Thermo Fisher Scientific stock is Moderate Buy based on the current 2 hold ratings and 14 buy ratings for TMO. The average twelve-month price prediction for Thermo Fisher Scientific is $593.94 with a high price target of $711.00 and a low price target of $475.00. Learn more on TMO's analyst rating history.

Do Wall Street analysts like Thermo Fisher Scientific more than its competitors?

Analysts like Thermo Fisher Scientific more than other Medical companies. The consensus rating score for Thermo Fisher Scientific is 2.88 while the average consensus rating score for medical companies is 2.68. Learn more on how TMO compares to other companies.

Is Thermo Fisher Scientific being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Thermo Fisher Scientific's stock had 1 upgrade and 1 downgrade by analysts.

Does Thermo Fisher Scientific's stock price have much upside?

According to analysts, Thermo Fisher Scientific's stock has a predicted upside of 17.02% based on their 12-month stock forecasts.

What analysts cover Thermo Fisher Scientific?

Thermo Fisher Scientific has been rated by Barclays, Citigroup, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stifel Nicolaus, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:TMO) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -